Publication: Alterations in the Renal Elastin-Elastase System in Type 1 Diabetic Nephropathy Identified by Proteomic Analysis
Issued Date
2004-03-01
Resource Type
ISSN
10466673
Other identifier(s)
2-s2.0-10744221885
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of the American Society of Nephrology. Vol.15, No.3 (2004), 650-662
Suggested Citation
Visith Thongboonkerd, Michelle T. Barati, Kenneth R. McLeish, Charaf Benarafa, Eileen Remold-O'Donnell, Shirong Zheng, Brad H. Rovin, William M. Pierce, Paul N. Epstein, Jon B. Klein Alterations in the Renal Elastin-Elastase System in Type 1 Diabetic Nephropathy Identified by Proteomic Analysis. Journal of the American Society of Nephrology. Vol.15, No.3 (2004), 650-662. doi:10.1097/01.ASN.0000115334.65095.9B Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/21724
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Alterations in the Renal Elastin-Elastase System in Type 1 Diabetic Nephropathy Identified by Proteomic Analysis
Abstract
Diabetes now accounts for >40% of patients with ESRD. Despite significant progress in understanding diabetic nephropathy, the cellular mechanisms that lead to diabetes-induced renal damage are incompletely defined. For defining changes in protein expression that accompany diabetic nephropathy, the renal proteome of 120-d-old OVE26 transgenic mice with hypoinsulinemia, hyperglycemia, hyperlipidemia, and proteinuria were compared with those of background FVB nondiabetic mice (n = 5). Proteins derived from whole-kidney lysate were separated by two-dimensional PAGE and identified by matrix-assisted laser desorption ionization-time-of-flight (MALDI-TOF) mass spectrometry. Forty-one proteins from 300 visualized protein spots were differentially expressed in diabetic kidneys. Among these altered proteins, expression of monocyte/neutrophil elastase inhibitor was increased, whereas elastase IIIB was decreased, leading to the hypothesis that elastin expression would be increased in diabetic kidneys. Renal immunohistochemistry for elastin of 325-d-old FVB and OVE26 mice demonstrated marked accumulation of elastin in the macula densa, collecting ducts, and pelvicalyceal epithelia of diabetic kidneys. Elastin immunohistochemistry of human renal biopsies from patients with type 1 diabetes (n = 3) showed increased elastin expression in renal tubular cells and the interstitium but not glomeruli. These results suggest that coordinated changes in elastase inhibitor and elastase expression result in increased tubulointerstitial deposition of elastin in diabetic nephropathy. The identification of these coordinated changes in protein expression in diabetic nephropathy indicates the potential value of proteomic analysis in defining pathophysiology.